MetaVia MTVA
NASDAQ MTVA
$1.39 +0.05 (+3.73%)
At close: Oct 22, 2026 · 4:00 PM EDT

MetaVia (MTVA) Amortization of Deferred Charges (2017 - 2019)

Updated

Analysis

MetaVia (MTVA) Amortization of Deferred Charges (2017 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 MetaVia 9.14 Mn -45.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 822,000.00
Dec 31, 2018 99,000.00
Sep 30, 2018 93,000.00
Jun 30, 2018 77,000.00
Mar 31, 2018 77,000.00
Dec 31, 2017 79,000.00
API Access

MetaVia Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=MTVA&period=max&api_key=YOUR_API_KEY